Doximity (NYSE:DOCS) Rating Increased to Moderate Buy at Needham & Company LLC

Doximity (NYSE:DOCS) was upgraded by equities researchers at Needham & Company LLC to a “moderate buy” rating in a note issued to investors on Friday,Zacks.com reports.

A number of other research firms have also recently weighed in on DOCS. Wall Street Zen cut shares of Doximity from a “buy” rating to a “hold” rating in a research report on Saturday, January 10th. Barclays raised shares of Doximity to a “strong-buy” rating in a research note on Monday, December 8th. Zacks Research raised shares of Doximity from a “hold” rating to a “strong-buy” rating in a research report on Monday, January 26th. Truist Financial raised shares of Doximity from a “hold” rating to a “strong-buy” rating in a research note on Thursday, January 8th. Finally, The Goldman Sachs Group upgraded Doximity from a “strong sell” rating to a “hold” rating in a research report on Friday, January 9th. Three equities research analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $55.00.

Doximity Price Performance

Shares of Doximity stock opened at $27.76 on Friday. The company has a market capitalization of $5.23 billion, a PE ratio of 23.13, a P/E/G ratio of 1.55 and a beta of 1.39. Doximity has a one year low of $23.66 and a one year high of $85.21.

Doximity Company Profile

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.